|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Organic Compounds -- Part Of The Class 532-570 Series > Azo Compounds Containing Formaldehyde Reaction Product As The Coupling Component > Carbohydrates Or Derivatives > Hetero Ring Is Six-membered Having Two Or More Ring Hetero Atoms Of Which At Least One Is Nitrogen (e.g., Selenazines, Etc.) > The Six-membered Hetero Ring Consists Of Two Nitrogens And Four Carbons (e.g., 1,2-diazines, Etc.) > Chalcogen Bonded Directly To Ring Carbon Of A 1,2-diazine Ring > Plural Diazine Rings Plural Diazine RingsPlural Diazine Rings patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/28/06 - 20060293519 - Method for producing cyclic diamine derivative or salt thereof (wherein Ar represents a phenyl group, a pyridyl group, or a pyrimidinyl group, any of which may have a substituent; X represents NH, S, or O; ring A represents a benzene ring or a pyridine ring, which may have a substituent; 1 represents an integer of 1 or 2; m ... 11/16/06 - 20060258863 - Synthesis of ccr5 antagonists The present invention is directed to the synthesis of 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], and intermediates therefor from readily available starting materials by a novel route. ... 10/26/06 - 20060241296 - Vanilloid receptor ligands and their use in treatments and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic ... 10/26/06 - 20060241295 - Preparation of pharmaceutical salts of piperazine compounds The present invention is generally directed to a process to directly prepare pharmaceutically acceptable salts enriched with respect to selected rotameric salts of a basic compound, by creative choice of an acid and a solvent medium. The process is particularly useful in preparing specific rotamers of pharmaceutically useful salts in ... 09/28/06 - 20060217553 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof as are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes ... 08/03/06 - 20060173182 - Process of preparing imatinib and imatinib prepared thereby A process of preparing imatinib, either as the free base or as an acid addition salt, which process comprises reacting N-(2-methyl-5-aminophenyl-4-(3-pyridyl)-2-pyrimidine amine of formula (II) with a 4-(4-methyl-piperazino methyl)benzoyl halide of formula (III) in the presence of an inert organic solvent, so as to yield a hydrohalide salt of imatinib ... 07/06/06 - 20060149062 - Sulfanyl substituted phenyl methanones R1, R2, R3, X, X1, and n are as defined in the specification and pharmaceutically acceptable acid addition salts thereof. These compounds are good inhibitors of the glycine transporter 1 (GlyT-1) for the treatment CNS disorders, such as schizophrenia, cognitive impairment, and Alzheimer's disease. ... 07/06/06 - 20060149061 - Novel process for preparing imatinib A novel process is disclosed for producing Imatinib, using the precursor 2-chloro-4-(3-pyridyl)-pyrimidine, thus improving Imatinib preparation via an alternative synthetic route, avoiding the use of the toxic reagent cyanamide. ... 06/22/06 - 20060135770 - Parp inhibitors where Q is O or S. ... 06/08/06 - 20060122394 - Substituted biaryl piperazinyl-pyridine analogues wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptors activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods ... 03/09/06 - 20060052603 - Process for preparing substituted phenoxy-acetic acids from phenols comprising the preparation of a compound of formula (II). ... 01/26/06 - 20060020133 - 3-aminocyclopentanecarboxamides as modulators of chemokine receptors which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity. ... 10/06/05 - 20050222414 - Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase This invention comprises the novel compounds of formula (I) wherein n, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine. ... 09/29/05 - 20050215788 - Method for the purification of piribedil A method for purifying Piribedil includes mixing Piribedil solid having a purity of 98% by weight with water, boiling the mixture, adding slowly 95% ethanol to the boiling mixture to form a clear liquid, filtering the hot clear liquid, cooling the filtrate to obtain a white crystal having a purity ... 08/04/05 - 20050171350 - Benzhydryl derivatives The object compound of the present invention has pharmacological activities such as Tachykinin antagonism, and is useful for manufacture of a medicament for treating or preventing Tachykinin-mediated diseases. ... 07/28/05 - 20050165233 - Continuous process for producing hydroxyazapirones by oxidation A method for continuous production of hydroxyazapirones, for example 6-hydroxybuspirone, using a modified reactor. The products of the invention are useful as pharmaceutical agents. ... ### FreshPatents.com Support |